Global Radiopharmaceutical Market Analysis and Forecast 2024-2030
Summary
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
According to APO Research, The global Radiopharmaceutical market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Radiopharmaceutical include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Radiopharmaceutical, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Radiopharmaceutical, also provides the sales of main regions and countries. Of the upcoming market potential for Radiopharmaceutical, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Radiopharmaceutical sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Radiopharmaceutical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Radiopharmaceutical sales, projected growth trends, production technology, application and end-user industry.
Radiopharmaceutical segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Radiopharmaceutical in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Radiopharmaceutical manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radiopharmaceutical sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
According to APO Research, The global Radiopharmaceutical market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Radiopharmaceutical include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Radiopharmaceutical, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Radiopharmaceutical, also provides the sales of main regions and countries. Of the upcoming market potential for Radiopharmaceutical, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Radiopharmaceutical sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Radiopharmaceutical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Radiopharmaceutical sales, projected growth trends, production technology, application and end-user industry.
Radiopharmaceutical segment by Company
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
- IBA Group
- GE Healthcare
- China Isotope & Radiation
- Jubilant Pharma
- Eli Lilly
- Advanced Accelerator Applications
- SIEMENS
- Dongcheng
- Navidea
- Actinium-225
- Lutetium-177
- Radium-223
- Holmium-166
- Other
- Oncology
- Cardiology
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Radiopharmaceutical in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Radiopharmaceutical manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radiopharmaceutical sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Radiopharmaceutical Market by Type
1.2.1 Global Radiopharmaceutical Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Actinium-225
1.2.3 Lutetium-177
1.2.4 Radium-223
1.2.5 Holmium-166
1.2.6 Other
1.3 Radiopharmaceutical Market by Application
1.3.1 Global Radiopharmaceutical Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 RADIOPHARMACEUTICAL MARKET DYNAMICS
2.1 Radiopharmaceutical Industry Trends
2.2 Radiopharmaceutical Industry Drivers
2.3 Radiopharmaceutical Industry Opportunities and Challenges
2.4 Radiopharmaceutical Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Radiopharmaceutical Revenue Estimates and Forecasts (2019-2030)
3.2 Global Radiopharmaceutical Revenue by Region
3.2.1 Global Radiopharmaceutical Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Radiopharmaceutical Revenue by Region (2019-2024)
3.2.3 Global Radiopharmaceutical Revenue by Region (2025-2030)
3.2.4 Global Radiopharmaceutical Revenue Market Share by Region (2019-2030)
3.3 Global Radiopharmaceutical Sales Estimates and Forecasts 2019-2030
3.4 Global Radiopharmaceutical Sales by Region
3.4.1 Global Radiopharmaceutical Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Radiopharmaceutical Sales by Region (2019-2024)
3.4.3 Global Radiopharmaceutical Sales by Region (2025-2030)
3.4.4 Global Radiopharmaceutical Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Radiopharmaceutical Revenue by Manufacturers
4.1.1 Global Radiopharmaceutical Revenue by Manufacturers (2019-2024)
4.1.2 Global Radiopharmaceutical Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Radiopharmaceutical Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Radiopharmaceutical Sales by Manufacturers
4.2.1 Global Radiopharmaceutical Sales by Manufacturers (2019-2024)
4.2.2 Global Radiopharmaceutical Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Radiopharmaceutical Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Radiopharmaceutical Sales Price by Manufacturers (2019-2024)
4.4 Global Radiopharmaceutical Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Radiopharmaceutical Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Radiopharmaceutical Manufacturers, Product Type & Application
4.7 Global Radiopharmaceutical Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Radiopharmaceutical Market CR5 and HHI
4.8.2 2023 Radiopharmaceutical Tier 1, Tier 2, and Tier
5 RADIOPHARMACEUTICAL MARKET BY TYPE
5.1 Global Radiopharmaceutical Revenue by Type
5.1.1 Global Radiopharmaceutical Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Radiopharmaceutical Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Radiopharmaceutical Revenue Market Share by Type (2019-2030)
5.2 Global Radiopharmaceutical Sales by Type
5.2.1 Global Radiopharmaceutical Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Radiopharmaceutical Sales by Type (2019-2030) & (M Doses)
5.2.3 Global Radiopharmaceutical Sales Market Share by Type (2019-2030)
5.3 Global Radiopharmaceutical Price by Type
6 RADIOPHARMACEUTICAL MARKET BY APPLICATION
6.1 Global Radiopharmaceutical Revenue by Application
6.1.1 Global Radiopharmaceutical Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Radiopharmaceutical Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Radiopharmaceutical Revenue Market Share by Application (2019-2030)
6.2 Global Radiopharmaceutical Sales by Application
6.2.1 Global Radiopharmaceutical Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Radiopharmaceutical Sales by Application (2019-2030) & (M Doses)
6.2.3 Global Radiopharmaceutical Sales Market Share by Application (2019-2030)
6.3 Global Radiopharmaceutical Price by Application
7 COMPANY PROFILES
7.1 Bracco Imaging
7.1.1 Bracco Imaging Comapny Information
7.1.2 Bracco Imaging Business Overview
7.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Bracco Imaging Radiopharmaceutical Product Portfolio
7.1.5 Bracco Imaging Recent Developments
7.2 Bayer
7.2.1 Bayer Comapny Information
7.2.2 Bayer Business Overview
7.2.3 Bayer Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Bayer Radiopharmaceutical Product Portfolio
7.2.5 Bayer Recent Developments
7.3 Mallinckrodt
7.3.1 Mallinckrodt Comapny Information
7.3.2 Mallinckrodt Business Overview
7.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Mallinckrodt Radiopharmaceutical Product Portfolio
7.3.5 Mallinckrodt Recent Developments
7.4 Nordion
7.4.1 Nordion Comapny Information
7.4.2 Nordion Business Overview
7.4.3 Nordion Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Nordion Radiopharmaceutical Product Portfolio
7.4.5 Nordion Recent Developments
7.5 Triad Isotopes
7.5.1 Triad Isotopes Comapny Information
7.5.2 Triad Isotopes Business Overview
7.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Triad Isotopes Radiopharmaceutical Product Portfolio
7.5.5 Triad Isotopes Recent Developments
7.6 Lantheus
7.6.1 Lantheus Comapny Information
7.6.2 Lantheus Business Overview
7.6.3 Lantheus Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Lantheus Radiopharmaceutical Product Portfolio
7.6.5 Lantheus Recent Developments
7.7 IBA Group
7.7.1 IBA Group Comapny Information
7.7.2 IBA Group Business Overview
7.7.3 IBA Group Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 IBA Group Radiopharmaceutical Product Portfolio
7.7.5 IBA Group Recent Developments
7.8 GE Healthcare
7.8.1 GE Healthcare Comapny Information
7.8.2 GE Healthcare Business Overview
7.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 GE Healthcare Radiopharmaceutical Product Portfolio
7.8.5 GE Healthcare Recent Developments
7.9 China Isotope & Radiation
7.9.1 China Isotope & Radiation Comapny Information
7.9.2 China Isotope & Radiation Business Overview
7.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 China Isotope & Radiation Radiopharmaceutical Product Portfolio
7.9.5 China Isotope & Radiation Recent Developments
7.10 Jubilant Pharma
7.10.1 Jubilant Pharma Comapny Information
7.10.2 Jubilant Pharma Business Overview
7.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Jubilant Pharma Radiopharmaceutical Product Portfolio
7.10.5 Jubilant Pharma Recent Developments
7.11 Eli Lilly
7.11.1 Eli Lilly Comapny Information
7.11.2 Eli Lilly Business Overview
7.11.3 Eli Lilly Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Eli Lilly Radiopharmaceutical Product Portfolio
7.11.5 Eli Lilly Recent Developments
7.12 Advanced Accelerator Applications
7.12.1 Advanced Accelerator Applications Comapny Information
7.12.2 Advanced Accelerator Applications Business Overview
7.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
7.12.5 Advanced Accelerator Applications Recent Developments
7.13 SIEMENS
7.13.1 SIEMENS Comapny Information
7.13.2 SIEMENS Business Overview
7.13.3 SIEMENS Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 SIEMENS Radiopharmaceutical Product Portfolio
7.13.5 SIEMENS Recent Developments
7.14 Dongcheng
7.14.1 Dongcheng Comapny Information
7.14.2 Dongcheng Business Overview
7.14.3 Dongcheng Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 Dongcheng Radiopharmaceutical Product Portfolio
7.14.5 Dongcheng Recent Developments
7.15 Navidea
7.15.1 Navidea Comapny Information
7.15.2 Navidea Business Overview
7.15.3 Navidea Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.15.4 Navidea Radiopharmaceutical Product Portfolio
7.15.5 Navidea Recent Developments
8 NORTH AMERICA
8.1 North America Radiopharmaceutical Market Size by Type
8.1.1 North America Radiopharmaceutical Revenue by Type (2019-2030)
8.1.2 North America Radiopharmaceutical Sales by Type (2019-2030)
8.1.3 North America Radiopharmaceutical Price by Type (2019-2030)
8.2 North America Radiopharmaceutical Market Size by Application
8.2.1 North America Radiopharmaceutical Revenue by Application (2019-2030)
8.2.2 North America Radiopharmaceutical Sales by Application (2019-2030)
8.2.3 North America Radiopharmaceutical Price by Application (2019-2030)
8.3 North America Radiopharmaceutical Market Size by Country
8.3.1 North America Radiopharmaceutical Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Radiopharmaceutical Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Radiopharmaceutical Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Radiopharmaceutical Market Size by Type
9.1.1 Europe Radiopharmaceutical Revenue by Type (2019-2030)
9.1.2 Europe Radiopharmaceutical Sales by Type (2019-2030)
9.1.3 Europe Radiopharmaceutical Price by Type (2019-2030)
9.2 Europe Radiopharmaceutical Market Size by Application
9.2.1 Europe Radiopharmaceutical Revenue by Application (2019-2030)
9.2.2 Europe Radiopharmaceutical Sales by Application (2019-2030)
9.2.3 Europe Radiopharmaceutical Price by Application (2019-2030)
9.3 Europe Radiopharmaceutical Market Size by Country
9.3.1 Europe Radiopharmaceutical Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Radiopharmaceutical Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Radiopharmaceutical Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Radiopharmaceutical Market Size by Type
10.1.1 China Radiopharmaceutical Revenue by Type (2019-2030)
10.1.2 China Radiopharmaceutical Sales by Type (2019-2030)
10.1.3 China Radiopharmaceutical Price by Type (2019-2030)
10.2 China Radiopharmaceutical Market Size by Application
10.2.1 China Radiopharmaceutical Revenue by Application (2019-2030)
10.2.2 China Radiopharmaceutical Sales by Application (2019-2030)
10.2.3 China Radiopharmaceutical Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Radiopharmaceutical Market Size by Type
11.1.1 Asia Radiopharmaceutical Revenue by Type (2019-2030)
11.1.2 Asia Radiopharmaceutical Sales by Type (2019-2030)
11.1.3 Asia Radiopharmaceutical Price by Type (2019-2030)
11.2 Asia Radiopharmaceutical Market Size by Application
11.2.1 Asia Radiopharmaceutical Revenue by Application (2019-2030)
11.2.2 Asia Radiopharmaceutical Sales by Application (2019-2030)
11.2.3 Asia Radiopharmaceutical Price by Application (2019-2030)
11.3 Asia Radiopharmaceutical Market Size by Country
11.3.1 Asia Radiopharmaceutical Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Radiopharmaceutical Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Radiopharmaceutical Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Radiopharmaceutical Market Size by Type
12.1.1 MEALA Radiopharmaceutical Revenue by Type (2019-2030)
12.1.2 MEALA Radiopharmaceutical Sales by Type (2019-2030)
12.1.3 MEALA Radiopharmaceutical Price by Type (2019-2030)
12.2 MEALA Radiopharmaceutical Market Size by Application
12.2.1 MEALA Radiopharmaceutical Revenue by Application (2019-2030)
12.2.2 MEALA Radiopharmaceutical Sales by Application (2019-2030)
12.2.3 MEALA Radiopharmaceutical Price by Application (2019-2030)
12.3 MEALA Radiopharmaceutical Market Size by Country
12.3.1 MEALA Radiopharmaceutical Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Radiopharmaceutical Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Radiopharmaceutical Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Radiopharmaceutical Value Chain Analysis
13.1.1 Radiopharmaceutical Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Radiopharmaceutical Production Mode & Process
13.2 Radiopharmaceutical Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Radiopharmaceutical Distributors
13.2.3 Radiopharmaceutical Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
1.1 Product Definition
1.2 Radiopharmaceutical Market by Type
1.2.1 Global Radiopharmaceutical Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Actinium-225
1.2.3 Lutetium-177
1.2.4 Radium-223
1.2.5 Holmium-166
1.2.6 Other
1.3 Radiopharmaceutical Market by Application
1.3.1 Global Radiopharmaceutical Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 RADIOPHARMACEUTICAL MARKET DYNAMICS
2.1 Radiopharmaceutical Industry Trends
2.2 Radiopharmaceutical Industry Drivers
2.3 Radiopharmaceutical Industry Opportunities and Challenges
2.4 Radiopharmaceutical Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Radiopharmaceutical Revenue Estimates and Forecasts (2019-2030)
3.2 Global Radiopharmaceutical Revenue by Region
3.2.1 Global Radiopharmaceutical Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Radiopharmaceutical Revenue by Region (2019-2024)
3.2.3 Global Radiopharmaceutical Revenue by Region (2025-2030)
3.2.4 Global Radiopharmaceutical Revenue Market Share by Region (2019-2030)
3.3 Global Radiopharmaceutical Sales Estimates and Forecasts 2019-2030
3.4 Global Radiopharmaceutical Sales by Region
3.4.1 Global Radiopharmaceutical Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Radiopharmaceutical Sales by Region (2019-2024)
3.4.3 Global Radiopharmaceutical Sales by Region (2025-2030)
3.4.4 Global Radiopharmaceutical Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Radiopharmaceutical Revenue by Manufacturers
4.1.1 Global Radiopharmaceutical Revenue by Manufacturers (2019-2024)
4.1.2 Global Radiopharmaceutical Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Radiopharmaceutical Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Radiopharmaceutical Sales by Manufacturers
4.2.1 Global Radiopharmaceutical Sales by Manufacturers (2019-2024)
4.2.2 Global Radiopharmaceutical Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Radiopharmaceutical Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Radiopharmaceutical Sales Price by Manufacturers (2019-2024)
4.4 Global Radiopharmaceutical Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Radiopharmaceutical Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Radiopharmaceutical Manufacturers, Product Type & Application
4.7 Global Radiopharmaceutical Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Radiopharmaceutical Market CR5 and HHI
4.8.2 2023 Radiopharmaceutical Tier 1, Tier 2, and Tier
5 RADIOPHARMACEUTICAL MARKET BY TYPE
5.1 Global Radiopharmaceutical Revenue by Type
5.1.1 Global Radiopharmaceutical Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Radiopharmaceutical Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Radiopharmaceutical Revenue Market Share by Type (2019-2030)
5.2 Global Radiopharmaceutical Sales by Type
5.2.1 Global Radiopharmaceutical Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Radiopharmaceutical Sales by Type (2019-2030) & (M Doses)
5.2.3 Global Radiopharmaceutical Sales Market Share by Type (2019-2030)
5.3 Global Radiopharmaceutical Price by Type
6 RADIOPHARMACEUTICAL MARKET BY APPLICATION
6.1 Global Radiopharmaceutical Revenue by Application
6.1.1 Global Radiopharmaceutical Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Radiopharmaceutical Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Radiopharmaceutical Revenue Market Share by Application (2019-2030)
6.2 Global Radiopharmaceutical Sales by Application
6.2.1 Global Radiopharmaceutical Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Radiopharmaceutical Sales by Application (2019-2030) & (M Doses)
6.2.3 Global Radiopharmaceutical Sales Market Share by Application (2019-2030)
6.3 Global Radiopharmaceutical Price by Application
7 COMPANY PROFILES
7.1 Bracco Imaging
7.1.1 Bracco Imaging Comapny Information
7.1.2 Bracco Imaging Business Overview
7.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Bracco Imaging Radiopharmaceutical Product Portfolio
7.1.5 Bracco Imaging Recent Developments
7.2 Bayer
7.2.1 Bayer Comapny Information
7.2.2 Bayer Business Overview
7.2.3 Bayer Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Bayer Radiopharmaceutical Product Portfolio
7.2.5 Bayer Recent Developments
7.3 Mallinckrodt
7.3.1 Mallinckrodt Comapny Information
7.3.2 Mallinckrodt Business Overview
7.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Mallinckrodt Radiopharmaceutical Product Portfolio
7.3.5 Mallinckrodt Recent Developments
7.4 Nordion
7.4.1 Nordion Comapny Information
7.4.2 Nordion Business Overview
7.4.3 Nordion Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Nordion Radiopharmaceutical Product Portfolio
7.4.5 Nordion Recent Developments
7.5 Triad Isotopes
7.5.1 Triad Isotopes Comapny Information
7.5.2 Triad Isotopes Business Overview
7.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Triad Isotopes Radiopharmaceutical Product Portfolio
7.5.5 Triad Isotopes Recent Developments
7.6 Lantheus
7.6.1 Lantheus Comapny Information
7.6.2 Lantheus Business Overview
7.6.3 Lantheus Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Lantheus Radiopharmaceutical Product Portfolio
7.6.5 Lantheus Recent Developments
7.7 IBA Group
7.7.1 IBA Group Comapny Information
7.7.2 IBA Group Business Overview
7.7.3 IBA Group Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 IBA Group Radiopharmaceutical Product Portfolio
7.7.5 IBA Group Recent Developments
7.8 GE Healthcare
7.8.1 GE Healthcare Comapny Information
7.8.2 GE Healthcare Business Overview
7.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 GE Healthcare Radiopharmaceutical Product Portfolio
7.8.5 GE Healthcare Recent Developments
7.9 China Isotope & Radiation
7.9.1 China Isotope & Radiation Comapny Information
7.9.2 China Isotope & Radiation Business Overview
7.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 China Isotope & Radiation Radiopharmaceutical Product Portfolio
7.9.5 China Isotope & Radiation Recent Developments
7.10 Jubilant Pharma
7.10.1 Jubilant Pharma Comapny Information
7.10.2 Jubilant Pharma Business Overview
7.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Jubilant Pharma Radiopharmaceutical Product Portfolio
7.10.5 Jubilant Pharma Recent Developments
7.11 Eli Lilly
7.11.1 Eli Lilly Comapny Information
7.11.2 Eli Lilly Business Overview
7.11.3 Eli Lilly Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Eli Lilly Radiopharmaceutical Product Portfolio
7.11.5 Eli Lilly Recent Developments
7.12 Advanced Accelerator Applications
7.12.1 Advanced Accelerator Applications Comapny Information
7.12.2 Advanced Accelerator Applications Business Overview
7.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
7.12.5 Advanced Accelerator Applications Recent Developments
7.13 SIEMENS
7.13.1 SIEMENS Comapny Information
7.13.2 SIEMENS Business Overview
7.13.3 SIEMENS Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 SIEMENS Radiopharmaceutical Product Portfolio
7.13.5 SIEMENS Recent Developments
7.14 Dongcheng
7.14.1 Dongcheng Comapny Information
7.14.2 Dongcheng Business Overview
7.14.3 Dongcheng Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 Dongcheng Radiopharmaceutical Product Portfolio
7.14.5 Dongcheng Recent Developments
7.15 Navidea
7.15.1 Navidea Comapny Information
7.15.2 Navidea Business Overview
7.15.3 Navidea Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
7.15.4 Navidea Radiopharmaceutical Product Portfolio
7.15.5 Navidea Recent Developments
8 NORTH AMERICA
8.1 North America Radiopharmaceutical Market Size by Type
8.1.1 North America Radiopharmaceutical Revenue by Type (2019-2030)
8.1.2 North America Radiopharmaceutical Sales by Type (2019-2030)
8.1.3 North America Radiopharmaceutical Price by Type (2019-2030)
8.2 North America Radiopharmaceutical Market Size by Application
8.2.1 North America Radiopharmaceutical Revenue by Application (2019-2030)
8.2.2 North America Radiopharmaceutical Sales by Application (2019-2030)
8.2.3 North America Radiopharmaceutical Price by Application (2019-2030)
8.3 North America Radiopharmaceutical Market Size by Country
8.3.1 North America Radiopharmaceutical Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Radiopharmaceutical Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Radiopharmaceutical Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Radiopharmaceutical Market Size by Type
9.1.1 Europe Radiopharmaceutical Revenue by Type (2019-2030)
9.1.2 Europe Radiopharmaceutical Sales by Type (2019-2030)
9.1.3 Europe Radiopharmaceutical Price by Type (2019-2030)
9.2 Europe Radiopharmaceutical Market Size by Application
9.2.1 Europe Radiopharmaceutical Revenue by Application (2019-2030)
9.2.2 Europe Radiopharmaceutical Sales by Application (2019-2030)
9.2.3 Europe Radiopharmaceutical Price by Application (2019-2030)
9.3 Europe Radiopharmaceutical Market Size by Country
9.3.1 Europe Radiopharmaceutical Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Radiopharmaceutical Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Radiopharmaceutical Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Radiopharmaceutical Market Size by Type
10.1.1 China Radiopharmaceutical Revenue by Type (2019-2030)
10.1.2 China Radiopharmaceutical Sales by Type (2019-2030)
10.1.3 China Radiopharmaceutical Price by Type (2019-2030)
10.2 China Radiopharmaceutical Market Size by Application
10.2.1 China Radiopharmaceutical Revenue by Application (2019-2030)
10.2.2 China Radiopharmaceutical Sales by Application (2019-2030)
10.2.3 China Radiopharmaceutical Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Radiopharmaceutical Market Size by Type
11.1.1 Asia Radiopharmaceutical Revenue by Type (2019-2030)
11.1.2 Asia Radiopharmaceutical Sales by Type (2019-2030)
11.1.3 Asia Radiopharmaceutical Price by Type (2019-2030)
11.2 Asia Radiopharmaceutical Market Size by Application
11.2.1 Asia Radiopharmaceutical Revenue by Application (2019-2030)
11.2.2 Asia Radiopharmaceutical Sales by Application (2019-2030)
11.2.3 Asia Radiopharmaceutical Price by Application (2019-2030)
11.3 Asia Radiopharmaceutical Market Size by Country
11.3.1 Asia Radiopharmaceutical Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Radiopharmaceutical Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Radiopharmaceutical Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Radiopharmaceutical Market Size by Type
12.1.1 MEALA Radiopharmaceutical Revenue by Type (2019-2030)
12.1.2 MEALA Radiopharmaceutical Sales by Type (2019-2030)
12.1.3 MEALA Radiopharmaceutical Price by Type (2019-2030)
12.2 MEALA Radiopharmaceutical Market Size by Application
12.2.1 MEALA Radiopharmaceutical Revenue by Application (2019-2030)
12.2.2 MEALA Radiopharmaceutical Sales by Application (2019-2030)
12.2.3 MEALA Radiopharmaceutical Price by Application (2019-2030)
12.3 MEALA Radiopharmaceutical Market Size by Country
12.3.1 MEALA Radiopharmaceutical Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Radiopharmaceutical Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Radiopharmaceutical Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Radiopharmaceutical Value Chain Analysis
13.1.1 Radiopharmaceutical Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Radiopharmaceutical Production Mode & Process
13.2 Radiopharmaceutical Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Radiopharmaceutical Distributors
13.2.3 Radiopharmaceutical Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
LIST OF TABLES
Table 1. Global Radiopharmaceutical Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Actinium-225 Major Manufacturers
Table 3. Lutetium-177 Major Manufacturers
Table 4. Radium-223 Major Manufacturers
Table 5. Holmium-166 Major Manufacturers
Table 6. Other Major Manufacturers
Table 7. Global Radiopharmaceutical Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 8. Oncology Major Manufacturers
Table 9. Cardiology Major Manufacturers
Table 10. Other Major Manufacturers
Table 11. Radiopharmaceutical Industry Trends
Table 12. Radiopharmaceutical Industry Drivers
Table 13. Radiopharmaceutical Industry Opportunities and Challenges
Table 14. Radiopharmaceutical Industry Restraints
Table 15. Global Radiopharmaceutical Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Radiopharmaceutical Revenue by Region (2019-2024) & (US$ Million)
Table 17. Global Radiopharmaceutical Revenue by Region (2025-2030) & (US$ Million)
Table 18. Global Radiopharmaceutical Revenue Market Share by Region (2019-2024)
Table 19. Global Radiopharmaceutical Revenue Market Share by Region (2025-2030)
Table 20. Global Radiopharmaceutical Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 21. Global Radiopharmaceutical Sales by Region (2019-2024) & (M Doses)
Table 22. Global Radiopharmaceutical Sales by Region (2025-2030) & (M Doses)
Table 23. Global Radiopharmaceutical Sales Market Share by Region (2019-2024)
Table 24. Global Radiopharmaceutical Sales Market Share by Region (2025-2030)
Table 25. Global Radiopharmaceutical Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 26. Global Radiopharmaceutical Revenue Market Share by Manufacturers (2019-2024)
Table 27. Global Radiopharmaceutical Sales by Manufacturers (US$ Million) & (2019-2024)
Table 28. Global Radiopharmaceutical Sales Market Share by Manufacturers (2019-2024)
Table 29. Global Radiopharmaceutical Sales Price (USD/Dose) of Manufacturers (2019-2024)
Table 30. Global Radiopharmaceutical Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 31. Global Radiopharmaceutical Key Manufacturers Manufacturing Sites & Headquarters
Table 32. Global Radiopharmaceutical Manufacturers, Product Type & Application
Table 33. Global Radiopharmaceutical Manufacturers Commercialization Time
Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Radiopharmaceutical by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 36. Global Radiopharmaceutical Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 37. Global Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
Table 38. Global Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
Table 39. Global Radiopharmaceutical Revenue Market Share by Type (2019-2024)
Table 40. Global Radiopharmaceutical Revenue Market Share by Type (2025-2030)
Table 41. Global Radiopharmaceutical Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 42. Global Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 43. Global Radiopharmaceutical Sales by Type (2025-2030) & (M Doses)
Table 44. Global Radiopharmaceutical Sales Market Share by Type (2019-2024)
Table 45. Global Radiopharmaceutical Sales Market Share by Type (2025-2030)
Table 46. Global Radiopharmaceutical Price by Type (2019-2024) & (USD/Dose)
Table 47. Global Radiopharmaceutical Price by Type (2025-2030) & (USD/Dose)
Table 48. Global Radiopharmaceutical Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 49. Global Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
Table 50. Global Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
Table 51. Global Radiopharmaceutical Revenue Market Share by Application (2019-2024)
Table 52. Global Radiopharmaceutical Revenue Market Share by Application (2025-2030)
Table 53. Global Radiopharmaceutical Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 54. Global Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 55. Global Radiopharmaceutical Sales by Application (2025-2030) & (M Doses)
Table 56. Global Radiopharmaceutical Sales Market Share by Application (2019-2024)
Table 57. Global Radiopharmaceutical Sales Market Share by Application (2025-2030)
Table 58. Global Radiopharmaceutical Price by Application (2019-2024) & (USD/Dose)
Table 59. Global Radiopharmaceutical Price by Application (2025-2030) & (USD/Dose)
Table 60. Bracco Imaging Company Information
Table 61. Bracco Imaging Business Overview
Table 62. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 63. Bracco Imaging Radiopharmaceutical Product Portfolio
Table 64. Bracco Imaging Recent Development
Table 65. Bayer Company Information
Table 66. Bayer Business Overview
Table 67. Bayer Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 68. Bayer Radiopharmaceutical Product Portfolio
Table 69. Bayer Recent Development
Table 70. Mallinckrodt Company Information
Table 71. Mallinckrodt Business Overview
Table 72. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 73. Mallinckrodt Radiopharmaceutical Product Portfolio
Table 74. Mallinckrodt Recent Development
Table 75. Nordion Company Information
Table 76. Nordion Business Overview
Table 77. Nordion Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 78. Nordion Radiopharmaceutical Product Portfolio
Table 79. Nordion Recent Development
Table 80. Triad Isotopes Company Information
Table 81. Triad Isotopes Business Overview
Table 82. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 83. Triad Isotopes Radiopharmaceutical Product Portfolio
Table 84. Triad Isotopes Recent Development
Table 85. Lantheus Company Information
Table 86. Lantheus Business Overview
Table 87. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 88. Lantheus Radiopharmaceutical Product Portfolio
Table 89. Lantheus Recent Development
Table 90. IBA Group Company Information
Table 91. IBA Group Business Overview
Table 92. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 93. IBA Group Radiopharmaceutical Product Portfolio
Table 94. IBA Group Recent Development
Table 95. GE Healthcare Company Information
Table 96. GE Healthcare Business Overview
Table 97. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 98. GE Healthcare Radiopharmaceutical Product Portfolio
Table 99. GE Healthcare Recent Development
Table 100. China Isotope & Radiation Company Information
Table 101. China Isotope & Radiation Business Overview
Table 102. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 103. China Isotope & Radiation Radiopharmaceutical Product Portfolio
Table 104. China Isotope & Radiation Recent Development
Table 105. Jubilant Pharma Company Information
Table 106. Jubilant Pharma Business Overview
Table 107. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 108. Jubilant Pharma Radiopharmaceutical Product Portfolio
Table 109. Jubilant Pharma Recent Development
Table 110. Eli Lilly Company Information
Table 111. Eli Lilly Business Overview
Table 112. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 113. Eli Lilly Radiopharmaceutical Product Portfolio
Table 114. Eli Lilly Recent Development
Table 115. Advanced Accelerator Applications Company Information
Table 116. Advanced Accelerator Applications Business Overview
Table 117. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 118. Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
Table 119. Advanced Accelerator Applications Recent Development
Table 120. SIEMENS Company Information
Table 121. SIEMENS Business Overview
Table 122. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 123. SIEMENS Radiopharmaceutical Product Portfolio
Table 124. SIEMENS Recent Development
Table 125. Dongcheng Company Information
Table 126. Dongcheng Business Overview
Table 127. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 128. Dongcheng Radiopharmaceutical Product Portfolio
Table 129. Dongcheng Recent Development
Table 130. Navidea Company Information
Table 131. Navidea Business Overview
Table 132. Navidea Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 133. Navidea Radiopharmaceutical Product Portfolio
Table 134. Navidea Recent Development
Table 135. North America Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
Table 136. North America Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
Table 137. North America Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 138. North America Radiopharmaceutical Sales by Type (2025-2030) & (M Doses)
Table 139. North America Radiopharmaceutical Sales Price by Type (2019-2024) & (USD/Dose)
Table 140. North America Radiopharmaceutical Sales Price by Type (2025-2030) & (USD/Dose)
Table 141. North America Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
Table 142. North America Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
Table 143. North America Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 144. North America Radiopharmaceutical Sales by Application (2025-2030) & (M Doses)
Table 145. North America Radiopharmaceutical Sales Price by Application (2019-2024) & (USD/Dose)
Table 146. North America Radiopharmaceutical Sales Price by Application (2025-2030) & (USD/Dose)
Table 147. North America Radiopharmaceutical Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 148. North America Radiopharmaceutical Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 149. North America Radiopharmaceutical Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 150. North America Radiopharmaceutical Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 151. North America Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 152. North America Radiopharmaceutical Sales by Country (2025-2030) & (M Doses)
Table 153. North America Radiopharmaceutical Sales Price by Country (2019-2024) & (USD/Dose)
Table 154. North America Radiopharmaceutical Sales Price by Country (2025-2030) & (USD/Dose)
Table 155. US Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 156. Canada Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 157. Europe Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
Table 158. Europe Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
Table 159. Europe Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 160. Europe Radiopharmaceutical Sales by Type (2025-2030) & (M Doses)
Table 161. Europe Radiopharmaceutical Sales Price by Type (2019-2024) & (USD/Dose)
Table 162. Europe Radiopharmaceutical Sales Price by Type (2025-2030) & (USD/Dose)
Table 163. Europe Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
Table 164. Europe Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
Table 165. Europe Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 166. Europe Radiopharmaceutical Sales by Application (2025-2030) & (M Doses)
Table 167. Europe Radiopharmaceutical Sales Price by Application (2019-2024) & (USD/Dose)
Table 168. Europe Radiopharmaceutical Sales Price by Application (2025-2030) & (USD/Dose)
Table 169. Europe Radiopharmaceutical Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 170. Europe Radiopharmaceutical Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 171. Europe Radiopharmaceutical Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 172. Europe Radiopharmaceutical Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 173. Europe Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 174. Europe Radiopharmaceutical Sales by Country (2025-2030) & (M Doses)
Table 175. Europe Radiopharmaceutical Sales Price by Country (2019-2024) & (USD/Dose)
Table 176. Europe Radiopharmaceutical Sales Price by Country (2025-2030) & (USD/Dose)
Table 177. Germany Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 178. France Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 179. Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 180. Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 181. Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 182. China Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
Table 183. China Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
Table 184. China Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 185. China Radiopharmaceutical Sales by Type (2025-2030) & (M Doses)
Table 186. China Radiopharmaceutical Sales Price by Type (2019-2024) & (USD/Dose)
Table 187. China Radiopharmaceutical Sales Price by Type (2025-2030) & (USD/Dose)
Table 188. China Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
Table 189. China Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
Table 190. China Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 191. China Radiopharmaceutical Sales by Application (2025-2030) & (M Doses)
Table 192. China Radiopharmaceutical Sales Price by Application (2019-2024) & (USD/Dose)
Table 193. China Radiopharmaceutical Sales Price by Application (2025-2030) & (USD/Dose)
Table 194. Asia Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
Table 195. Asia Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
Table 196. Asia Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 197. Asia Radiopharmaceutical Sales by Type (2025-2030) & (M Doses)
Table 198. Asia Radiopharmaceutical Sales Price by Type (2019-2024) & (USD/Dose)
Table 199. Asia Radiopharmaceutical Sales Price by Type (2025-2030) & (USD/Dose)
Table 200. Asia Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
Table 201. Asia Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
Table 202. Asia Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 203. Asia Radiopharmaceutical Sales by Application (2025-2030) & (M Doses)
Table 204. Asia Radiopharmaceutical Sales Price by Application (2019-2024) & (USD/Dose)
Table 205. Asia Radiopharmaceutical Sales Price by Application (2025-2030) & (USD/Dose)
Table 206. Asia Radiopharmaceutical Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 207. Asia Radiopharmaceutical Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 208. Asia Radiopharmaceutical Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 209. Asia Radiopharmaceutical Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 210. Asia Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 211. Asia Radiopharmaceutical Sales by Country (2025-2030) & (M Doses)
Table 212. Asia Radiopharmaceutical Sales Price by Country (2019-2024) & (USD/Dose)
Table 213. Asia Radiopharmaceutical Sales Price by Country (2025-2030) & (USD/Dose)
Table 214. Japan Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 215. South Korea Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 216. Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 217. Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 218. Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 219. Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 220. Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 221. Radiopharmaceutical Revenue (2019-2030)
Table 1. Global Radiopharmaceutical Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Actinium-225 Major Manufacturers
Table 3. Lutetium-177 Major Manufacturers
Table 4. Radium-223 Major Manufacturers
Table 5. Holmium-166 Major Manufacturers
Table 6. Other Major Manufacturers
Table 7. Global Radiopharmaceutical Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 8. Oncology Major Manufacturers
Table 9. Cardiology Major Manufacturers
Table 10. Other Major Manufacturers
Table 11. Radiopharmaceutical Industry Trends
Table 12. Radiopharmaceutical Industry Drivers
Table 13. Radiopharmaceutical Industry Opportunities and Challenges
Table 14. Radiopharmaceutical Industry Restraints
Table 15. Global Radiopharmaceutical Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Radiopharmaceutical Revenue by Region (2019-2024) & (US$ Million)
Table 17. Global Radiopharmaceutical Revenue by Region (2025-2030) & (US$ Million)
Table 18. Global Radiopharmaceutical Revenue Market Share by Region (2019-2024)
Table 19. Global Radiopharmaceutical Revenue Market Share by Region (2025-2030)
Table 20. Global Radiopharmaceutical Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 21. Global Radiopharmaceutical Sales by Region (2019-2024) & (M Doses)
Table 22. Global Radiopharmaceutical Sales by Region (2025-2030) & (M Doses)
Table 23. Global Radiopharmaceutical Sales Market Share by Region (2019-2024)
Table 24. Global Radiopharmaceutical Sales Market Share by Region (2025-2030)
Table 25. Global Radiopharmaceutical Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 26. Global Radiopharmaceutical Revenue Market Share by Manufacturers (2019-2024)
Table 27. Global Radiopharmaceutical Sales by Manufacturers (US$ Million) & (2019-2024)
Table 28. Global Radiopharmaceutical Sales Market Share by Manufacturers (2019-2024)
Table 29. Global Radiopharmaceutical Sales Price (USD/Dose) of Manufacturers (2019-2024)
Table 30. Global Radiopharmaceutical Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 31. Global Radiopharmaceutical Key Manufacturers Manufacturing Sites & Headquarters
Table 32. Global Radiopharmaceutical Manufacturers, Product Type & Application
Table 33. Global Radiopharmaceutical Manufacturers Commercialization Time
Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Radiopharmaceutical by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 36. Global Radiopharmaceutical Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 37. Global Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
Table 38. Global Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
Table 39. Global Radiopharmaceutical Revenue Market Share by Type (2019-2024)
Table 40. Global Radiopharmaceutical Revenue Market Share by Type (2025-2030)
Table 41. Global Radiopharmaceutical Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 42. Global Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 43. Global Radiopharmaceutical Sales by Type (2025-2030) & (M Doses)
Table 44. Global Radiopharmaceutical Sales Market Share by Type (2019-2024)
Table 45. Global Radiopharmaceutical Sales Market Share by Type (2025-2030)
Table 46. Global Radiopharmaceutical Price by Type (2019-2024) & (USD/Dose)
Table 47. Global Radiopharmaceutical Price by Type (2025-2030) & (USD/Dose)
Table 48. Global Radiopharmaceutical Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 49. Global Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
Table 50. Global Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
Table 51. Global Radiopharmaceutical Revenue Market Share by Application (2019-2024)
Table 52. Global Radiopharmaceutical Revenue Market Share by Application (2025-2030)
Table 53. Global Radiopharmaceutical Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 54. Global Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 55. Global Radiopharmaceutical Sales by Application (2025-2030) & (M Doses)
Table 56. Global Radiopharmaceutical Sales Market Share by Application (2019-2024)
Table 57. Global Radiopharmaceutical Sales Market Share by Application (2025-2030)
Table 58. Global Radiopharmaceutical Price by Application (2019-2024) & (USD/Dose)
Table 59. Global Radiopharmaceutical Price by Application (2025-2030) & (USD/Dose)
Table 60. Bracco Imaging Company Information
Table 61. Bracco Imaging Business Overview
Table 62. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 63. Bracco Imaging Radiopharmaceutical Product Portfolio
Table 64. Bracco Imaging Recent Development
Table 65. Bayer Company Information
Table 66. Bayer Business Overview
Table 67. Bayer Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 68. Bayer Radiopharmaceutical Product Portfolio
Table 69. Bayer Recent Development
Table 70. Mallinckrodt Company Information
Table 71. Mallinckrodt Business Overview
Table 72. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 73. Mallinckrodt Radiopharmaceutical Product Portfolio
Table 74. Mallinckrodt Recent Development
Table 75. Nordion Company Information
Table 76. Nordion Business Overview
Table 77. Nordion Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 78. Nordion Radiopharmaceutical Product Portfolio
Table 79. Nordion Recent Development
Table 80. Triad Isotopes Company Information
Table 81. Triad Isotopes Business Overview
Table 82. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 83. Triad Isotopes Radiopharmaceutical Product Portfolio
Table 84. Triad Isotopes Recent Development
Table 85. Lantheus Company Information
Table 86. Lantheus Business Overview
Table 87. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 88. Lantheus Radiopharmaceutical Product Portfolio
Table 89. Lantheus Recent Development
Table 90. IBA Group Company Information
Table 91. IBA Group Business Overview
Table 92. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 93. IBA Group Radiopharmaceutical Product Portfolio
Table 94. IBA Group Recent Development
Table 95. GE Healthcare Company Information
Table 96. GE Healthcare Business Overview
Table 97. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 98. GE Healthcare Radiopharmaceutical Product Portfolio
Table 99. GE Healthcare Recent Development
Table 100. China Isotope & Radiation Company Information
Table 101. China Isotope & Radiation Business Overview
Table 102. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 103. China Isotope & Radiation Radiopharmaceutical Product Portfolio
Table 104. China Isotope & Radiation Recent Development
Table 105. Jubilant Pharma Company Information
Table 106. Jubilant Pharma Business Overview
Table 107. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 108. Jubilant Pharma Radiopharmaceutical Product Portfolio
Table 109. Jubilant Pharma Recent Development
Table 110. Eli Lilly Company Information
Table 111. Eli Lilly Business Overview
Table 112. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 113. Eli Lilly Radiopharmaceutical Product Portfolio
Table 114. Eli Lilly Recent Development
Table 115. Advanced Accelerator Applications Company Information
Table 116. Advanced Accelerator Applications Business Overview
Table 117. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 118. Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
Table 119. Advanced Accelerator Applications Recent Development
Table 120. SIEMENS Company Information
Table 121. SIEMENS Business Overview
Table 122. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 123. SIEMENS Radiopharmaceutical Product Portfolio
Table 124. SIEMENS Recent Development
Table 125. Dongcheng Company Information
Table 126. Dongcheng Business Overview
Table 127. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 128. Dongcheng Radiopharmaceutical Product Portfolio
Table 129. Dongcheng Recent Development
Table 130. Navidea Company Information
Table 131. Navidea Business Overview
Table 132. Navidea Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 133. Navidea Radiopharmaceutical Product Portfolio
Table 134. Navidea Recent Development
Table 135. North America Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
Table 136. North America Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
Table 137. North America Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 138. North America Radiopharmaceutical Sales by Type (2025-2030) & (M Doses)
Table 139. North America Radiopharmaceutical Sales Price by Type (2019-2024) & (USD/Dose)
Table 140. North America Radiopharmaceutical Sales Price by Type (2025-2030) & (USD/Dose)
Table 141. North America Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
Table 142. North America Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
Table 143. North America Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 144. North America Radiopharmaceutical Sales by Application (2025-2030) & (M Doses)
Table 145. North America Radiopharmaceutical Sales Price by Application (2019-2024) & (USD/Dose)
Table 146. North America Radiopharmaceutical Sales Price by Application (2025-2030) & (USD/Dose)
Table 147. North America Radiopharmaceutical Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 148. North America Radiopharmaceutical Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 149. North America Radiopharmaceutical Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 150. North America Radiopharmaceutical Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 151. North America Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 152. North America Radiopharmaceutical Sales by Country (2025-2030) & (M Doses)
Table 153. North America Radiopharmaceutical Sales Price by Country (2019-2024) & (USD/Dose)
Table 154. North America Radiopharmaceutical Sales Price by Country (2025-2030) & (USD/Dose)
Table 155. US Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 156. Canada Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 157. Europe Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
Table 158. Europe Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
Table 159. Europe Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 160. Europe Radiopharmaceutical Sales by Type (2025-2030) & (M Doses)
Table 161. Europe Radiopharmaceutical Sales Price by Type (2019-2024) & (USD/Dose)
Table 162. Europe Radiopharmaceutical Sales Price by Type (2025-2030) & (USD/Dose)
Table 163. Europe Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
Table 164. Europe Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
Table 165. Europe Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 166. Europe Radiopharmaceutical Sales by Application (2025-2030) & (M Doses)
Table 167. Europe Radiopharmaceutical Sales Price by Application (2019-2024) & (USD/Dose)
Table 168. Europe Radiopharmaceutical Sales Price by Application (2025-2030) & (USD/Dose)
Table 169. Europe Radiopharmaceutical Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 170. Europe Radiopharmaceutical Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 171. Europe Radiopharmaceutical Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 172. Europe Radiopharmaceutical Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 173. Europe Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 174. Europe Radiopharmaceutical Sales by Country (2025-2030) & (M Doses)
Table 175. Europe Radiopharmaceutical Sales Price by Country (2019-2024) & (USD/Dose)
Table 176. Europe Radiopharmaceutical Sales Price by Country (2025-2030) & (USD/Dose)
Table 177. Germany Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 178. France Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 179. Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 180. Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 181. Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 182. China Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
Table 183. China Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
Table 184. China Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 185. China Radiopharmaceutical Sales by Type (2025-2030) & (M Doses)
Table 186. China Radiopharmaceutical Sales Price by Type (2019-2024) & (USD/Dose)
Table 187. China Radiopharmaceutical Sales Price by Type (2025-2030) & (USD/Dose)
Table 188. China Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
Table 189. China Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
Table 190. China Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 191. China Radiopharmaceutical Sales by Application (2025-2030) & (M Doses)
Table 192. China Radiopharmaceutical Sales Price by Application (2019-2024) & (USD/Dose)
Table 193. China Radiopharmaceutical Sales Price by Application (2025-2030) & (USD/Dose)
Table 194. Asia Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
Table 195. Asia Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
Table 196. Asia Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 197. Asia Radiopharmaceutical Sales by Type (2025-2030) & (M Doses)
Table 198. Asia Radiopharmaceutical Sales Price by Type (2019-2024) & (USD/Dose)
Table 199. Asia Radiopharmaceutical Sales Price by Type (2025-2030) & (USD/Dose)
Table 200. Asia Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
Table 201. Asia Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
Table 202. Asia Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 203. Asia Radiopharmaceutical Sales by Application (2025-2030) & (M Doses)
Table 204. Asia Radiopharmaceutical Sales Price by Application (2019-2024) & (USD/Dose)
Table 205. Asia Radiopharmaceutical Sales Price by Application (2025-2030) & (USD/Dose)
Table 206. Asia Radiopharmaceutical Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 207. Asia Radiopharmaceutical Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 208. Asia Radiopharmaceutical Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 209. Asia Radiopharmaceutical Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 210. Asia Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 211. Asia Radiopharmaceutical Sales by Country (2025-2030) & (M Doses)
Table 212. Asia Radiopharmaceutical Sales Price by Country (2019-2024) & (USD/Dose)
Table 213. Asia Radiopharmaceutical Sales Price by Country (2025-2030) & (USD/Dose)
Table 214. Japan Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 215. South Korea Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 216. Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 217. Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 218. Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 219. Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 220. Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Table 221. Radiopharmaceutical Revenue (2019-2030)
